Clozapine toxicity and hepatitis

Journal of Clinical Psychopharmacology

Volumn 33, Issue 4, 2013, Pages 570-571

  Brown, Cara A ^a   Telio, Summer ^b   Warnock, Caroline A ^a   Wong, Albert H C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CLOZAPINE; HALOPERIDOL; HEMOGLOBIN; LAXATIVE; NORCLOZAPINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CLOTTING TEST; CASE REPORT; DIAPHORESIS; FEMALE; GENERAL HOSPITAL; HEMOGLOBIN BLOOD LEVEL; HEPATITIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LETHARGY; LETTER; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SPLENOMEGALY;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; MIDDLE AGED; RISK FACTORS; SCHIZOPHRENIA, PARANOID;

EID: 84879845547     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182946586     Document Type: Letter

References (18)

1. Narendran R, Young CM, Pristach CA, et al. Efficacy of clozapine in the treatment of atypical antipsychotic refractory schizophrenia: a pilot study. J Clin Psychopharmacol. 2003;23:103-104.
2. Hummer M, Kurz M, Kurzthaler I, et al. Hepatotoxicity of clozapine. J Clin Psychopharmacol. 1997;17:314-317.
3. Gaertner I, Altendorf K, Batra A, et al. Relevance of liver enzyme elevations with four different neuroleptics: a retrospective review of 7,263 treatment courses. J Clin Psychopharmacol. 2001;21:215-222.
4. Subramaniam M, Ng C, Chong SA, et al. Metabolic differences between Asian and Caucasian patients on clozapine treatment. Hum Psychopharmacol. 2007;22:217-222.
5. Kellner M, Wiedemann K, Krieg JC, et al. Toxic hepatitis by clozapine treatment. Am J Psychiatry. 1993;150:985-986.
6. Thatcher GW, Cates M, Bair B. Clozapine-induced toxic hepatitis. Am J Psychiatry. 1995;152:296-297.
7. Fong SY, Au Yeung KL, Tosh JM, et al. Clozapine-induced toxic hepatitis with skin rash. J Psychopharmacol. 2005;19:107.
8. Luo D, McColl P, Walmsley R. Acute onset of ascites with clozapine-induced hepatitis. Intern Med J. 2007;37:204-205.
9. Thompson J, Chengappa KN, Good CB, et al. Hepatitis, hyperglycemia, pleural effusion, eosinophilia, hematuria and proteinuria occurring early in clozapine treatment. Int Clin Psychopharmacol. 1998;13:95-98.
10. Patton S, Remick RA, Isomura T. ClozapineVan atypical reaction. Can J Psychiatry. 2000;45:393-394.
11. Macfarlane B, Davies S, Mannan K, et al.. Fatal acute fulminant liver failure due to clozapine: a case report and review of clozapine-induced hepatotoxicity. Gastroenterology. 1997;112:1707-1709.
12. Marinkovic D, Timotijevic I, Babinski T, et al. The side-effects of clozapine: a four year follow-up study. Prog Neuropsychopharmacol Biol Psychiatry. 1994;18:537-544.
13. Worrall R, Wilson A, Cullen M. Dystonia and drug-induced hepatitis in a patient treated with clozapine. Am J Psychiatry. 1995;152:647-648.
14. Cooper TB. Clozapine plasma level monitoring: current status. Psychiatr Q. 1996;67:297-311.
15. Ozdemir V, Kalow W, Posner P, et al. CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia. J Clin Psychopharmacol. 2001;21:398-407.
16. Andrade RJ, Tulkens PM. Hepatic safety of antibiotics used in primary care. J Antimicrob Chemother. 2011;66:1431-1446.
17. Erdogan A, Kocabasoglu N, Yalug I, et al. Management of marked liver enzyme increase during clozapine treatment: a case report and review of the literature. Int J Psychiatry Med. 2004;34:83-89.
18. Markowitz JS, Grinberg R, Jackson C. Marked liver enzyme elevations with clozapine. J Clin Psychopharmacol. 1997;17:70-71.